Derek Bunker
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Derek Bunker
The proxy statement of Pennant Group, Inc. reports total compensation of $365,312 for Derek Bunker in fiscal 2022, including a base salary of $233,000. Disclosed compensation is on record for 4 fiscal years. Derek Bunker has spoken on 2 earnings calls across 1 company, most recently for Pennant Group, Inc. on May 9, 2022.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Pennant Group, Inc. (PNTG)
Proxy statement
Start not stated–2022-04-14
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Pennant Group, Inc. (PNTG) | Chief Investment Officer | $233,000 | $365,312 |
| 2021 | Pennant Group, Inc. (PNTG) | Chief Investment Officer | $221,883 | $441,788 |
| 2020 | Pennant Group, Inc. (PNTG) | Chief Investment Officer | $213,451 | $572,044 |
| 2019 | Pennant Group, Inc. (PNTG) | Chief Investment Officer, Executive Vice President and Secretary Mr. Walker’s 2019 stock award consists of 1,192,842 restricted stock units in connection with the Spin-Off that will fully vest on the third anniversary of the grant. The restricted stock units were granted on October 1, 2019 with a fair value at the grant date of $15.09 per share. Mr. Walker was provided this one-time grant by the Board of Directors in recognition of his role as a founder of Cornerstone Healthcare, Inc., our home health and hospice subsidiary, which prior to the Spin-Off was a subsidiary of Ensign. 2019 total reflects compensation for the period after the Spin-Off earned from October 1, 2019, through December 31, 2019. Prior to October 1, 2019, the Company was a wholly owned subsidiary of Ensign, our former parent company. Prior to the Spin-Off, the cash compensation of our NEOs was determined by Ensign’s executive management or its board of directors and the equity compensation of our NEOs was determined by Ensign’s compensation committee at the recommendation of Ensign’s executive management. Accordingly, the compensation paid to our NEOs for fiscal year 2019 is not necessarily indicative of how we will compensate our named executive officers in future years. Mr. Guerisoli was appointed President of the Company effective January 1, 2021. Prior to that date, Mr. Guerisoli served as the President of the Company’s home health and hospice segment. | $52,500 | $380,769 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.